Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carfilzomib plus dexamethasone in relapsed/refractory multiple myeloma (China, phase 3)
CTR20160857Phase 3Completed
- Sponsor
- Onyx Pharmaceuticals
- Start
- Dec 2016
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carfilzomib in multiple myeloma (MM), sponsored by Onyx Pharmaceuticals. Started Dec 2016; status: completed.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on CTR20160857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160857.